Section of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Kidney360. 2023 Jan 1;4(1):98-101. doi: 10.34067/KID.0006602022.
Patients with obesity did not have any larger hematocrit drop after kidney biopsy compared with those without obesity. Patients with obesity had fewer glomeruli sampled from kidney biopsy compared with those without obesity. For patients with obesity, kidney biopsy is a safe procedure but may have lower diagnostic adequacy.
与非肥胖患者相比,肥胖患者在肾活检后血细胞比容下降幅度无差异。与非肥胖患者相比,肥胖患者的肾活检肾小球采样较少。对于肥胖患者,肾活检是一种安全的操作,但可能诊断准确性较低。